Stock Watch: Q2 Earnings Blowouts Resume At AstraZeneca And GSK

After A Week’s Break, The Continuation Of Earnings Season Reinforced Differences Between The First Two Quarters Of 2025

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.